Cramer cheers Monday’s tech gains, but tells investors to keep a diverse portfolio with an eye towards health care
CNBC's Jim Cramer detailed Monday's tech wins but told investors not to forget about health-care stocks. Source link
Read More
Bristol-Myers Squibb Co
Cramer’s week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
CNBC's Jim Cramer told investors to pay attention next week to the JPMorgan Healthcare Conference. Source link
Read More
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. A look at what 2024 might
Read More
Biden administration’s Medicare drug price negotiations will face major tests in 2024
Next year could set the precedent for the Inflation Reduction Act's controversial talks, which could affect dozens of medications by
Read More
Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push
Bristol Myers Squibb said on Tuesday it would buy RayzeBio for about $4.1 billion to bolster its cancer drug business.
Read More
Stocks making the biggest moves midday: Nike, Rocket Lab, Bristol Myers, NetEase and more
These are the stocks posting the largest moves in midday trading. Source link
Read More
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash. Source link
Read More
Goldman breaks down the laggard trade and gives its comeback picks for first quarter 2024
Goldman Sachs said that this year’s laggard stocks could be next quarter’s market outperformers. Source link
Read More
Stocks making the biggest moves midday: Microsoft, Chegg, Zoom Video, Paramount and more
These are the stocks posting the largest moves in midday trading. Source link
Read More